Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib

AIM: To evaluate the value of systemic inflammation-based markers as prognostic factors for advanced pancreatic cancer (PC). METHODS: Data from 82 patients who underwent combination chemotherapy with gemcitabine and erlotinib for PC from 2011 to 2014 were collected retrospectively. Data that include...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :World J Gastrointest Oncol
Главные авторы: Lee, Jae Min, Lee, Hong Sik, Hyun, Jong Jin, Choi, Hyuk Soon, Kim, Eun Sun, Keum, Bora, Seo, Yeon Seok, Jeen, Yoon Tae, Chun, Hoon Jai, Um, Soon Ho, Kim, Chang Duck
Формат: Artigo
Язык:Inglês
Опубликовано: Baishideng Publishing Group Inc 2016
Предметы:
Retrospective Study
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4942744/
https://ncbi.nlm.nih.gov/pubmed/27559435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v8.i7.555
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы